BOSTON'S PREMIER LEGAL LIFE SCIENCES CONFERENCE
CONNECTING LAWYERS & INDUSTRY
With emerging technologies and rapidly expanding business sectors come new legal issues. This fall, the Boston Bar will host the annual Life Sciences Conference, featuring speakers and discussion exploring the interplay between the life sciences sector and the law.
Home to biotech startups, leading research institutions, multinational pharmaceutical companies, and venture capital firms, Boston is at the forefront of the life science industry and the Boston Bar is the industry’s hub for legal expertise. Don’t miss the premier networking conference for life sciences practitioners.
Please check back here as the conference committee pulls together the conference content and some outstanding speakers.
Tuesday, October 3, 2017
8:00 AM – 4:00 PM
Boston Marriott Cambridge – Kendall Square
CEO and President
XTuit Pharmaceuticals, Inc.
Professor of Management Practice
Harvard Business School
University Research Agreements
Disclosure Issues for Life Sciences Companies
Developments from DC
FDA Regulation Update
Life Science IPOs
The Fate of a License: Licensing Issues Small Companies Face When They Go Public
Licensing: Collaborating with Competitors
BBA Conferences and CLE Cancellation Policies
If you’re unable to attend a Conference for which you’ve registered, please contact the BBA by Wednesday, September 27th in order to receive a refund (less a $25 administrative fee). Registrants who are unable to attend may send a substitute attendee by providing the full name and work address of the substitute attendee the day before the program. Please contact Ashley Young at 617-778-1934 or email@example.com, regarding all cancellation matters.
Stay tuned for the complete conference agenda and speaker lineup!
For opportunities to get involved in the conference or other
Boston Bar conferences please contact Maggie Demoura at firstname.lastname@example.org
2017 CONFERENCE ADVISORY COMMITTEE
Greenberg Traurig LLP
Third Rock Ventures
Co-Chair Life Sciences Group,
Director of IP and Strategic Alliances,
MIT Koch Institute
Senior Partner and National Co-Chair Life Sciences Practice